Case Western Reserve University
Cleveland, Ohio, 44106, United States
Location status: Recruiting
Location contact
Emily Graczyk, Ph.D.
CONTACT
Emily Graczyk, Ph.D.
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07225582
The goal of this clinical trial is to learn more about how stimulating the nerves involved in sensation (either in the limbs or in the brain) can be used to restore sensation in participants who have a spinal cord injury. Participants in this study will have already been enrolled in the "Reconnecting the Hand and Arm to the Brain (ReHAB)" study, and received small electrodes in a part of the brain that is involved in sensing touch and pressure in the hand. The ReHAB study participants will also have received electrodes around the nerves in their arm. In this clinical trial, participants will receive two types of electrical stimulation:
* Intracortical microstimulation (ICMS) which involves sending small electrical pulses to the part of the brain that processes sensation. * Peripheral nerve stimulation (PNS) which involves sending small electrical pulses to the nerves in the arm that transmit sensations from the hand.
Researchers will try different patterns of stimulation for both ICMS and PNS and study how the participants perceive the sensations from the different stimulation patterns. The researchers will also study how combining ICMS and PNS affects the perceived sensations.
Interested in participating?
Request Info22 year–65 year
All sexes
Interventional
Not applicable
Cleveland, Ohio, 44106, United States
Location status: Recruiting
Emily Graczyk, Ph.D.
CONTACT
Emily Graczyk, Ph.D.
PRINCIPAL_INVESTIGATOR
The overall goal of this study is to compare the sensations that are perceived from intracortical microstimulation (ICMS) to those perceived from peripheral nerve stimulation (PNS), and also to perceived sensations from a combination of ICMS and PNS.
Preceding study
Participants for this study will be individuals with a high-level spinal cord injury who are already enrolled in the "Reconnecting the Hand and Arm to the Brain (ReHAB)" clinical trial (ID# NCT03898804). The ReHAB clinical trial involves receiving tiny electrode arrays in the brain and small electrodes around some of the nerves in the arm. The goal of the ReHAB clinical trial is to restore arm and hand movement and sensation in individuals with paralysis from a spinal cord injury.
Goals of this clinical trial
The purpose of the proposed study is to investigate the perception and functional impact of sensory neurostimulation in participants with tetraplegia. Investigators will develop and implement novel paradigms of ICMS applied to primary somatosensory cortex (S1) and PNS applied to upper extremity nerves through chronically-implanted cuff electrodes. Investigators will also develop and assess hybrid neurostimulation paradigms involving paired application of ICMS and PNS. For each paradigm, investigators will quantify the perceived sensation with classic psychophysical methods. Investigators will also implement the approach into closed-loop tasks in virtual reality controlled through decoded cortical signals recorded from intracortical microelectrode arrays. Finally, investigators will assess the impact of each stimulation paradigm on residual sensory function.
In Aim 1, investigators will develop a novel ICMS paradigm that attempts to reproduce both the temporal and spatial activation patterns that occur in S1 during normal touch. Investigators will compare this novel paradigm to other existing ICMS encoders. Investigators will assess the impact of each ICMS encoder on perceptual response, task performance in virtual reality (VR), and residual sensory function. In Aim 2, investigators will develop novel PNS paradigms and assess the efficacy of PNS for sensory feedback in people with tetraplegia for the first time. As in Aim 1, investigators will develop and compare several PNS encoders, including those that reproduce aspects of the peripheral response to normal touch and traditional linear encoders. We will assess the impact of each PNS encoder on perceptual response, task performance in VR, and residual sensory function. In Aim 3, we will develop hybrid neurostimulation paradigms that pair ICMS with PNS. We will assess the impact of stimulation encoder and stimulation amplitude on the perceived sensations generated by hybrid stimulation. We will then investigate the impact of PNS-ICMS timing delays within the hybrid neurostimulation paradigm on the perceptual response, functional impact, and impact on residual sensory function.
All participants will participate in all aims and will receive all stimulation approaches and perform all tasks and measures. All participants will serve as their own control for the planned statistical analyses. The study will generate tens of thousands of perceptual response data points, hundreds of functional task data points, and hundreds of thousands of intracortical recordings (for exploratory analyses).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants with tetraplegia who have received intracortical arrays in the sensory cortex and peripheral nerve cuff electrodes will undergo a variety of stimulation paradigms to investigate the perception and functional impact of sensory neurostimulation.
Time frame: From enrollment to around two years after enrollment
Percentage of force matching trials per block in which the target force was achieved before the time limit
Time frame: From enrollment to around two years after enrollment
Percentage of trials per block in which the correct object was identified
Time frame: From enrollment until around two years post-enrollment
Minimal change in stimulation that results in a reliably distinguishable change in perceived magnitude
Time frame: From enrollment to around two years after enrollment
Minimal mechanical stimulus, delivered by a tactor that the participant can reliably perceive
Time frame: From enrollment until around two years post-enrollment
Difference in minimum and maximum stimulation levels that elicit detectable, comfortable sensation
Time frame: From enrollment until around two years post-enrollment
The position of the sensory percept reported on a hand/arm diagram
Time frame: From enrollment to around two years after enrollment
The participant's description of the quality of the sensation evoked by stimulation, reported as a selection of descriptor words
Time frame: From enrollment until around two years post-enrollment
The participant's rating of the perceived naturalness of the stimulus on an open-ended scale
Time frame: From enrollment to around two years after enrollment
Minimal change in mechanical touch input that results in a reliably distinguishable change in perceived magnitude
Time frame: From enrollment to around two years after enrollment
The time elapsed from the go cue required for the participant to hit the force target
Time frame: From enrollment to around two years after enrollment
Percentage of posture matching trials per block in which the target posture was achieved before the time limit
Contact information is provided by the study sponsor or research team.
Case Western Reserve University
Other
Development of Optimal Sensory Feedback Strategies to Maximize Function After Tetraplegia: A Sub-study of the Reconnecting the Hand and Arm to the Brain (ReHAB) Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03680872
Central Nervous System Diseases, Nervous System Diseases
Manhasset, New York, United States
View Trial DetailsNCT06841770
Bronchial Diseases, Bronchiolitis
Downey, California, United States
View Trial DetailsNCT06939660
Bronchial Diseases, Bronchiolitis
Beijing, Beijing Municipality, China
View Trial DetailsNCT07361627
Central Nervous System Diseases, Nervous System Diseases
Montreal, Quebec, Canada
View Trial Details